Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Cerilliant
McKinsey
Queensland Health
Deloitte
McKesson
AstraZeneca
Boehringer Ingelheim
Citi

Generated: December 18, 2018

DrugPatentWatch Database Preview

Litigation Details for Nice Systems Inc. v. Witness Systems Inc. (D. Del. 2006)

« Back to Dashboard

Nice Systems Inc. v. Witness Systems Inc. (D. Del. 2006)

Docket ➤ Sign Up Date Filed 2006-05-10
Court District Court, D. Delaware Date Terminated 2008-08-13
Cause 35:271 Patent Infringement Assigned To Joseph James Farnan Jr.
Jury Demand Both Referred To
Parties NICE SYSTEMS INC.; NICE SYSTEMS LTD.; WITNESS SYSTEMS INC.
Patents 10,066,003; 9,005,599
Attorneys John D. Hamann; Josy W. Ingersoll; Karen Elizabeth Keller; Kyle Wagner Compton; Mary Frances Dugan; Melanie K. Sharp; Monte Terrell Squire; Nagendra Setty; William J. Marsden , Jr.
Firms Shaw Keller LLP; Young, Conaway, Stargatt & Taylor LLP
Link to Docket External link to docket
Biologic Drugs cited in Nice Systems Inc. v. Witness Systems Inc.
The biologic drugs covered by the patents cited in this case are ➤ Sign Up and ➤ Sign Up .

Details for Nice Systems Inc. v. Witness Systems Inc. (D. Del. 2006)

Date Filed Document No. Description Snippet Link To Document
2006-08-11 33 Declaration willing 54:-'4 55:22 68:21 wishes 52;3 63:10 66:3.8 6?:2 ?0:12 ?2:23 74:5 ?4:9 ?5:|?_.15 '36:…three additional patents were issued and assigned to STS. These patents, U.S. Patent Nos. 6,865,604 (“…original patent. Therefore, if STS were to surrender the ‘665 patent to the United States Patent & Trademark…original patent shall take effect upon the issue of the reissued patent, and every reissued patent shall …United States Patent Nos. 6,317,783 (“the ‘?83 patent"), 6,199,077 (“the ‘077 patent"), and External link to document
2008-02-20 357 Redacted Document 955 555§95 .~95@503 HHU .~950 599 "91.99`9©@5@.599.m 303 =9@ MmU n995 9§9 559 559 63§9 55 5 mE£.…them - ln-depth overview of current patent portfolio = Produce patent and competitive strategy (defensive… last meeting as to why patents are taking so long. 0 0.. The Witness Patent process is leveraging an… and patent analysis of Nice. 0 Council to spend cycles on addressing tactics and produce patent strategy…effectiveness of its patent portfolio. In addition, the Council-would review any potentially patentable concepts External link to document
Date Filed Document No. Description Snippet Link To Document

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Teva
Accenture
Argus Health
Medtronic
Chinese Patent Office
Covington
McKesson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.